Skip to main content
Publications
Yosipovitch G, Reaney M, Mastey V, Eckert L, Nelson L, Clark M, Abbe A, Ardeleanu M, Radin A, Gadkari A. Validation of the peak pruritus numerical rating scale: results from clinical studies of dupilumab in adults with moderate-to-severe atopic dermatitis. Poster presented at the 2017 American Academy of Dermatology Annual Meeting; March 4, 2017. Orlando, FL. [abstract] J Am Acad Dermatol. 2017 Jun; 76(6 Suppl 1):AB278. doi: 10.1016/j.jaad.2017.04.1082
Zijlema WL, Triguero-Mas M, Smith G, Cirach M, Martinez D, Dadvand P, Gascon M, Jones M, Gidlow C, Hurst G, Masterson D, Ellis N, van den Berg M, Maas J, van Kamp I, van den Hazel P, Kruize H, Nieuwenhuijsen MJ, Julvez J. The relationship between natural outdoor environments and cognitive functioning and its mediators. Environ Res. 2017 May;155:268-75. doi: 10.1016/j.envres.2017.02.017
Strober B, Gottlieb AB, Sherif B, Mollon P, Gilloteau I, McLeod L, Fox T, Mordin M, Gnanasakthy A, Papavassilis C, Lebwohl MG. Secukinumab sustains early patient-reported outcome benefits through 1 year: results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept. J Am Acad Dermatol. 2017 Apr;76(4):655-61. doi: 10.1016/j.jaad.2016.11.043